Yolande F. M. Ramos

Dr. Yolande F. M. Ramos

Leiden University Medical Center (LUMC), The Netherlands
+1
orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 October 2015 in Nature Communications
Verified
Journal Article
Open access
PDF file
MPMarjolein J. Peters
Marjolein J. Peters
RJRoby Joehanes
Roby Joehanes
LPLuke Pilling
Luke Pilling
CSClaudia Schurmann
Claudia Schurmann
KCKaren N. Conneely
Karen N. Conneely
AJAndrew D. Johnson
Andrew D. Johnson
Disease incidences increase with age, but the molecular characteristics of ageing that lead to increased disease susceptibility remain inadequately understood. Here we perform a whole-blood gene expression meta-analysis in 14,983 individuals of European ancestry (including replication) and identify 1,497 genes that are differentially expressed with chronological age. The age-associated genes do not harbor more age-associated CpG-methylation sites than other genes, but are instead enriched for the presence of potentially functional CpG-methylation sites in enhancer and insulator regions that associate with both chronological age and gene expression levels. We further used the gene expression profiles to calculate the ‘transcriptomic age’ of an individual, and show that differences between transcriptomic age and chronological age are associated with biological features linked to ageing, such as blood pressure, cholesterol levels, fasting glucose, and body mass index. The transcriptomic prediction model adds biological relevance and complements existing epigenetic prediction models, and can be used by others to calculate transcriptomic age in external cohorts.

2 November 2006 in Nature
Verified
Journal Article
Closed access
PDF file
NLNikia A. Laurie
Nikia A. Laurie
SDStacy L. Donovan
Stacy L. Donovan
CSChie-Schin Shih
Chie-Schin Shih
JZJiakun Zhang
Jiakun Zhang
NMNicholas Mills
Nicholas Mills
MDMichael A. Dyer
Michael A. Dyer

26 October 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
ATAlexander Teumer
Alexander Teumer
LCLayal Chaker
Layal Chaker
SGStefan Groeneweg
Stefan Groeneweg
YLYong Li
Yong Li
CMCelia Di Munno
Celia Di Munno
MMMarco Medici
Marco Medici
Thyroid dysfunction is an important public health problem, which affects 10% of the general population and increases the risk of cardiovascular morbidity and mortality. Many aspects of thyroid hormone regulation have only partly been elucidated, including its transport, metabolism, and genetic determinants. Here we report a large meta-analysis of genome-wide association studies for thyroid function and dysfunction, testing 8 million genetic variants in up to 72,167 individuals. One-hundred-and-nine independent genetic variants are associated with these traits. A genetic risk score, calculated to assess their combined effects on clinical end points, shows significant associations with increased risk of both overt (Graves’ disease) and subclinical thyroid disease, as well as clinical complications. By functional follow-up on selected signals, we identify a novel thyroid hormone transporter (SLC17A4) and a metabolizing enzyme (AADAT). Together, these results provide new knowledge about thyroid hormone physiology and disease, opening new possibilities for therapeutic targets.

23 July 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
YRYolande F. M. Ramos
Yolande F. M. Ramos
WHWouter Den Hollander
Wouter Den Hollander
Judith V.M.G. BovéeJudith V.M.G. Bovée
Judith V.M.G. Bovée
Nils BomerNils Bomer
Nils Bomer
RBRuud Van Der Breggen
Ruud Van Der Breggen
IMIngrid Meulenbelt
Ingrid Meulenbelt
Identify gene expression profiles associated with OA processes in articular cartilage and determine pathways changing during the disease process. Genome wide gene expression was determined in paired samples of OA affected and preserved cartilage of the same joint using microarray analysis for 33 patients of the RAAK study. Results were replicated in independent samples by RT-qPCR and immunohistochemistry. Profiles were analyzed with the online analysis tools DAVID and STRING to identify enrichment for specific pathways and protein-protein interactions. Among the 1717 genes that were significantly differently expressed between OA affected and preserved cartilage we found significant enrichment for genes involved in skeletal development (e.g. TNFRSF11B and FRZB). Also several inflammatory genes such as CD55, PTGES and TNFAIP6, previously identified in within-joint analyses as well as in analyses comparing preserved cartilage from OA affected joints versus healthy cartilage were among the top genes. Of note was the high up-regulation of NGF in OA cartilage. RT-qPCR confirmed differential expression for 18 out of 19 genes with expression changes of 2-fold or higher, and immunohistochemistry of selected genes showed a concordant change in protein expression. Most of these changes associated with OA severity (Mankin score) but were independent of joint-site or sex. We provide further insights into the ongoing OA pathophysiological processes in cartilage, in particular into differences in macroscopically intact cartilage compared to OA affected cartilage, which seem relatively consistent and independent of sex or joint. We advocate that development of treatment could benefit by focusing on these similarities in gene expression changes and/or pathways.

1 February 2016 in Nature Communications
Verified
Journal Article
Open access
PDF file
TKTuomas O. Kilpeläinen
Tuomas O. Kilpeläinen
JCJayne F. Martin Carli
Jayne F. Martin Carli
ASAlicja A. Skowronski
Alicja A. Skowronski
QSQi Sun
Qi Sun
JKJennifer Kriebel
Jennifer Kriebel
RLRuth J. F. Loos
Ruth J. F. Loos
Leptin is an adipocyte-secreted hormone, the circulating levels of which correlate closely with overall adiposity. Although rare mutations in the leptin (LEP) gene are well known to cause leptin deficiency and severe obesity, no common loci regulating circulating leptin levels have been uncovered. Therefore, we performed a genome-wide association study (GWAS) of circulating leptin levels from 32,161 individuals and followed up loci reaching P<10−6 in 19,979 additional individuals. We identify five loci robustly associated (P<5 × 10−8) with leptin levels in/near LEP, SLC32A1, GCKR, CCNL1 and FTO. Although the association of the FTO obesity locus with leptin levels is abolished by adjustment for BMI, associations of the four other loci are independent of adiposity. The GCKR locus was found associated with multiple metabolic traits in previous GWAS and the CCNL1 locus with birth weight. Knockdown experiments in mouse adipose tissue explants show convincing evidence for adipogenin, a regulator of adipocyte differentiation, as the novel causal gene in the SLC32A1 locus influencing leptin levels. Our findings provide novel insights into the regulation of leptin production by adipose tissue and open new avenues for examining the influence of variation in leptin levels on adiposity and metabolic health.

7 January 1999 in Oncogene
Verified
Journal Article
Closed access
VBVolker Böttger
Volker Böttger
ABAngelika Böttger
Angelika Böttger
CGCarlos Garcia-Echeverria
Carlos Garcia-Echeverria
YRYolande F. M. Ramos
Yolande F. M. Ramos
AEAlex J van der Eb
Alex J van der Eb
DLDavid Lane
David Lane